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Abstract
Transcriptional regulation depends upon the binding of transcription factor (TF) proteins to DNA in a sequence-dependent
manner. Although many experimental methods address the interaction between DNA and proteins, they generally do not
comprehensively and accurately assess the full binding repertoire (the complete set of sequences that might be bound with
at least moderate strength). Here, we develop and evaluate through simulation an experimental approach that allows
simultaneous high-throughput quantitative analysis of TF binding affinity to thousands of potential DNA ligands. Tens of
thousands of putative binding targets can be mixed with a TF, and both the pre-bound and bound target pools sequenced.
A hierarchical Bayesian Markov chain Monte Carlo approach determines posterior estimates for the dissociation constants,
sequence-specific binding energies, and free TF concentrations. A unique feature of our approach is that dissociation
constants are jointly estimated from their inferred degree of binding and from a model of binding energetics, depending on
how many sequence reads are available and the explanatory power of the energy model. Careful experimental design is
necessary to obtain accurate results over a wide range of dissociation constants. This approach, which we call Simultaneous
Ultra high-throughput Ligand Dissociation EXperiment (SULDEX), is theoretically capable of rapid and accurate elucidation
of an entire TF-binding repertoire.
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Introduction
Transcription is one of the most important control points for
gene expression and is regulated in eukaryotes through multiple
layers of control [1]. Sequence-specific DNA binding transcription
factors (TFs) bind to specific genomic sites in promoters and en-
hancers, recruit additional proteins to achieve opening of ch-
romatin, and ultimately assemble and activate RNA polymerase II
pre-initiation complexes. Such transcription factor binding sites
(TFBS) are essential to organismal function, yet there are subs-
tantial limitations in our current ability to predict the location and
function of these elements [2–8]. In addition, mutations in re-
gulatory sequences can easily alter transcription rates [9,10],
leading to the evolution of novel phenotypes, but the effects of
TFBS mutations on transcription are generally unpredictable.
This unpredictability exists partly because measuring TF-TFBS
binding affinities in a high-throughput way remains problematic
[11], and the number of large and accurate binding datasets
remains few [12,13]. To better understand the functional role of
TF and TFBS interactions that contribute to altering gene regu-
lation, methods capable of estimating such effects in a probabilistic
and high-throughput manner are an important area of research.
Here we focus on developing and testing a method that can be
applied in a high-throughput fashion to estimate the binding
affinities of TFs to their cognate TFBSs. Transcription is a process
driven by the biophysics of these interactions, and thus they are
often viewed as a necessary component to understanding tran-
scription and biological networks [11,14–24]. Our aim is that this
Bayesian method should work for both strong and moderate
binding relationships while taking into account the biophysical
properties of these interactions.
A number of approaches have been developed to characterize
details of how TFs bind to their cognate TFBSs. Established
methods like SELEX and its high-throughput extensions [25] are,
however, biased towards the highest affinity TFBSs. Other me-
thods, relying on technologies such as electrophoretic mobility shift
assays (EMSA), luciferase constructs, and proximity ligation ana-
lysis are labor-intensive or low throughput, and are typically used
only to examine the affinity of variants of a known consensus
binding site [26–29]. While protein-DNA binding microarrays
(PBM) are a quite useful high-throughput technology that assesses
binding of transcription factors to double-stranded DNA micro-
arrays [22,30–33] [31–33], PBMs make mostly qualitative
measurements [18–24]. PBMs are also highly susceptible to
inaccuracies due to loss of weakly bound material [11], while more
accurate microfluidic devices [11] rely on specialized equipment.
Other popular methods utilize chromatin immunoprecipitation
(ChIP) followed by microarrays (ChIP-chip) to provide low
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and this approach has been successfully employed for most of the
known yeast TFs [34,35] using microarrays of all intergenic
regions. Higher resolution methods are now available based on
ChIP followed by high density tiling arrays [36], by sequencing of
DNA using paired-end diTAG, ChIP-PET, [37] or by direct next
generation sequencing of ChIP products, [38,39]. Limitations of
ChIP-based methods are, however, that condition-specific protein
binding can result in low enrichment and that it can be difficult to
distinguish direct from indirect binding [22].
To generalize and extend characterization of measurement-
based estimates of TF and TFBS affinities, position weight ma-
trices (PWMs) have been used to summarize binding preferences
so that new sequences can be scored for their potential to bind a
specific TF. The PWM is based on nucleotide frequencies at each
position, assuming each position contributes independently to the
overall binding energy of the DNA-protein complex [40]. This
approximation is correct when the TF is at extremely low con-
centration. The seminal work of Berg and von Hippel [41] related
biophysical models of binding to the information content of the
nucleotide frequencies used to construct the PWMs. Since then,
biophysical models for DNA-protein interactions have been used
to estimate binding affinities for a TF to genomic sequences given
a PWM [42–46]. Several methods have been developed to es-
timate the energy terms in the biophysical model directly through
high-throughput studies such as ChIP-chip and PBM [13,47–50].
Many of the earlier methods assume low protein concentration
[48,50] for estimation or saturated occupancy [47]. More recently
the BayesPI [49] and BEEML [13] methods have introduced
models without these constraints.
In this paper, we introduce what we call a ‘‘Simultaneous Ultra-
high throughput Ligand Dissociation Experiment’’, or SULDEX.
To evaluate dissociation constants, this approach utilizes high-
throughput sequencing to count the relative numbers of short
synthetic duplex DNA segments (ds-oligos) in solution before and
after binding to a transcription factor. The goal of SULDEX is to:
1) simultaneously measure the relative binding abilities of large
numbers of ds-oligos; 2) construct a biophysical binding model that
can predict the energies of binding (and therefore the dissociation
constants); and 3) integrate individual count-based binding esti-
mates with model-based predictions informed by the entire reper-
toire; this allows better predictions of binding affinities when the
frequencies of particular ds-oligos are low (either before or after
binding). The SULDEX method is a Bayesian approach in which
we apply Markov chain Monte Carlo (MCMC) methodology to
obtain full posterior distributions of our unknown quantities.
SULDEX is comparable to two recently introduced techniques,
Bind-n-Seq [12] and HT-SELEX [13], which utilize similar
information. In contrast to SULDEX, the Bind-n-Seq approach
[12] is designed to obtain approximate binding motifs that were
previously unknown. As we demonstrate below, the Bind-n-Seq
experimental design leads to data with undesirable qualities in
terms of accurately measuring dissociation constants or binding
energies. HT-SELEX [13] has more similar goals to ours, but is a
maximum likelihood approach, and does not allow flexible asse-
ssment of binding model accuracy in the way that SULDEX does.
Also, in contrast to these existing approaches, we incorporate into
our method a means of predicting ds-oligo frequencies in the pre-
bound solution. This is often critical for accurate results as these
frequencies can easily vary by many orders of magnitude, even in
cases where the nucleotide synthesis was designed to create equal
ds-oligo frequencies. Furthermore, our method allows incorpora-
tion of multiple reference ds-oligos with known binding energies to
obtain accurate dissociation constants in the absence of a good
energy model. We evaluate the utility of our method using data
simulated for ds-oligos with known dissociation constants for the
Leu3 and ArcA transcription factors [26,28], and Zif268 data from
a Bind-n-Seq experiment [12]. Our results suggest that our Bay-
esian method can be used to accurately and precisely predict TF-
TFBS binding affinities across a broad range of binding specifi-
cities. In addition to developing and testing our method, we pro-
vide extended focus on the interaction of experimental design with
theoretical considerations.
Methods
Transcription factor binding
The binding interaction between a transcription factor, TF, and
a specific DNA sequence, Si, can be described by
TFzSi / ?
ki
a
ki
d
TF.Si, ð1Þ
where TF.Si is the complex of TF bound to Si, and ki
a and ki
d are
sequence-dependent rate constants of association of the compo-
nents and dissociation of the complex, respectively (also sometimes
known respectively as ki
on and ki
off). If ½TF , ½Si , and ½TF.Si  are
the concentrations in solution of TF, Si, and TF.Si, respectively,
then at equilibrium, ki
a½TF ½Si ~ki
d½TF.Si  by definition. If we
define the equilibrium constant Ki
D:ki
d=ki
a, the proportion of the
sequence that is bound at any point in time is given by
wi:
½TF.Si 
½Si z½TF.Si 
~
½TF 
Ki
Dz½TF 
ð2Þ
This relationship is at the basis of most methods for determining
Ki
D. The Ki
D can be related to the standard free energies of bind-
ing, DGi, using the relationship DGi~RT lnKi
D, where R is the
ideal gas constant and T is the temperature (0K). We note that this
formula can be rearranged to derive a ‘‘chemical potential’’, as in
[13,47,51], but this is not necessary. Also, we do not assume that
there is an unvarying non-specific binding component that is not
specific to the sequence, as in [13].
In the SULDEX protocol, many sequences are mixed together
in solution, and rather than measuring the proportion of a specific
sequence bound, one measures the relative proportion of different
sequences in both the pre-bound (v0
i ) and the bound mixtures
(vb
i ). Thus, if ½S
0
i   is the concentration of sequence Si in the
absence of transcription factors, and ½S
0
i  ~½Si z½TF.Si  in the
presence of a transcription factor, then we can estimate
v0
i ~½S
0
i  
.P
S
0
j
hi
and vb
i ~½TF.Si 
 P
½TF.Sj , by sequencing
and counting ds-oligos in the respective fractions. Note that we
assume here (as is necessary in most experiments) that the
frequencies in the bound fraction will not be affected by the
purification process. This is probably a good assumption for strong
binders, but will become problematic for weaker binders, for
which ki
d (known in this context as ki
off) can be relatively large. We
leave detailed consideration of this problem for future research.
We know that
vb
i ~v0
i wi
.X
j v0
j wj, ð3Þ
so by substituting this into Eqn. 2 and re-arranging, we can see
that if y~
P
j v0
j wj and ½TF  were known precisely, then the Ki
D
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Ki
D~
½TF  1-wi ðÞ
wi
~
½TF  1-vb
i y
 
v0
i
  
vb
i y
 
v0
i
: ð4Þ
It is worth pausing here to note that the probability of binding, wi,
can in theory also be predicted using a partition function, as
discussed by Stormo and colleagues [13]. In this context, Equation
3 has the same form as Equation 6 in that work, in which it is
viewed as an application of Bayes’ Theorem. We do not believe,
however, that these two equations are exactly equivalent. One
important difference is that here (as discussed in detail later) we
model ½TF  as a free (unknown) parameter. This allows us to avoid
the issue of predicting ½TF  from first principles based on binding
energies, conformations, and concentrations of the entire ensemble
of sequences in the mix. This also leads to a second important
difference, which is that given a known or inferred free ½TF , the
probability that each sequence is bound does not depend on the
other wi. Another way of putting this is that the wi only affect each
other through their effect on ½TF . As a consequence, our
Equation 3 should not be viewed as an application of Bayes’
Theorem, but rather a statement of physical transformation such
that the relative frequencies of molecules in the bound fraction will
depend upon their relative frequencies in the pre-bound fraction
multiplied by their probability of binding to the transcription
factor, given the concentration of transcription factor available in
solution at equilibrium. Furthermore, since this results in relative
frequencies, the result of Equation 3 is a relative proportion among
the sequences that have been chosen to be compared. In other
words, vb
i is not a posterior probability, but is instead formally a
proportion among sequences considered, and the comparator
sequences j in Equation 3 and elsewhere may be summed over any
desired subset of the sequences that were in the solutions.
In theory, v0
i and vb
i could be estimated as ^ v v0
i ~ci=
P
cj and
^ v vb
i ~bi=
P
bj, where the ci are the counts in the pre-bound
fraction, and the bi are the counts in the TF-bound fraction. Then,
given two known reference Kr
D, the two unknowns, ½TF  and y,
could be determined by solving the two ds-oligo-specific versions
of Eqn. 3 (i.e., two equations with two unknowns). All of the
unknown Ki
D could subsequently be estimated using these values.
In practice, however, it is preferable to take into account the
uncertainty in v0
i and vb
i . We chose to estimate all parameters
using Markov chain Monte Carlo estimation under a Bayesian
graphical model, described below, which can directly incorporate
parameter uncertainty and allow that uncertainty to propagate
properly through the conditional relationships. To reduce vari-
ance, it is also recommended that the reference sequences should
be represented at a high frequency in the pre-bound fraction, and
should be strong binders, so that they are highly represented in
both the bound and pre-bound fractions. To produce exact re-
ference dissociation constants in the basic binding model, at least
two reference sequences are required. We note that with the in-
corporation of the energy model below, it is not strictly necessary
to include reference sequences with known dissociation constants
(as demonstrated by Stormo and colleagues[13]), although without
reference dissociation constants only relative binding energies
(DDGs) are produced. However, since our goal is to allow the
results to depend more heavily on the count-based estimates of
dissociation constants (or binding energies) than on the energy
model (described below) in cases where the energy model appears
to be unreliable, we have included reference sequences in all the
analyses presented here, and highly recommend at least two
whenever it is possible.
A Bayesian graphical model for basic binding estimation
The goal of Markov chain Monte Carlo (MCMC) estimation is
to estimate the posterior density P(hjD)!P(Djh)P(h), where h are
the free parameters of a generative model and D is the data. In the
basic binding model (BBM), the data are the set of pre-bound
counts C~ ci fg and bound counts B~ bi fg , as well as a set of at
least two (Rw~2) known reference dissociation constants KR
D
(Figure 1). The parameters are the transcription factor concen-
tration in the bound solution ½TF , y~
P
j v0
j wj, the set of pre-
bound ds-oligo frequencies V
0~ v0
i
  
, the set of bound ds-oligo
frequencies V
b~ vb
i
  
, the set of binding probabilities W~ wi
  
,
the set of dissociation constants KD ={Ki
D} (not including the
reference dissociation constants KR
D), and the set of binding
energies DG~ DGi
  
. As frequency vectors, V
0 and V
b are
constrained by
P
v0
i ~1, 0v~v0
i v~1,
P
vb
i ~1, and 0v~
vb
i v~1. Due to the dependencies described above and depicted
in Figure 1, the sets V
0, V
b, W, KD and DG, as well as the
parameter ½TF , can all be calculated as functions of one another,
and there is considerable potential leeway in choosing which
parameters are free and which are not. In all implementations of
the BBM presented here, we have chosen to model V
0, ½TF , and
DG as free parameters, and calculated the remaining parameters
as functions of these free parameters. We also note that it would
not be difficult to include uncertainty about the reference
constants (Figure 1), but we have not implemented this here.
The probabilities of the observed ds-oligo counts in the pre-
bound and bound fractions are based on multinomials of the
parametric frequencies of each ds-oligo in solution,
C*Multi V
0, nC
  
and B*Multi V
b, nB
  
, ð5Þ
where nC~
P
i
ci and nB~
P
i
bi. The log of the likelihood,
Figure 1. Graphical representation of the basic binding model
(BBM). Observed variables (the pre-bound counts, C, the bound counts,
B, and the reference dissociation constants, KR
D) are in filled circles, and
unobserved variables (i.e., parameters V
0, V
b, W, y, ½TF , DG and KD)
are in hollow circles. Probabilistic dependencies and their directions are
shown with solid arrows, while deterministic dependencies are shown
with dashed arrows. There is some flexibility in the graphical model as to
which parameters arefree andwhich aredependent on the others. In the
implementations presented here, V
0, ½TF , and DG (thick bordered
circles) were allowed to vary in the MCMC analyses, while
V
b, W, y, and KD were calculated from the other parameters.
doi:10.1371/journal.pone.0026105.g001
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logL~log
X n
i
ci!
 !
z
X n
i
ci! ðÞ log v0
i
  
{log ci! ðÞ z
log
X
i
bi!
 !
z
X n
i
bi log vb
i
  
{log bi! ðÞ :
ð6Þ
As is clear from Figure 1, Equations 2 and 3, and our choice of free
parameters, the vb
i are calculated as functions of V
0, DG, ½TF ,
KR
D, and V
0.
We note that in this simple model, the main data-based con-
fostraints on V
b (other than the pre-bound and bound counts) arise
from the set of known reference dissociation constants KR
D that
directly affect only the two vb
i corresponding to the reference
sequences. The only further constraint on the system is that the
free transcription factor concentration in the bound fraction must
be less than the total transcription factor concentration, if it is
known from, for example, the amount of transcription factor
added to the solution (i.e., TF ½  ƒ TF0   
: TF ½  z
P
TF.Si ½  ). It
would be straightforward, however, to add further boundary
constraints or specify prior knowledge of any of the parameters
(whether free or not). For example, the proportion of transcription
factor in the unbound and bound fractions might be quantified,
there might be error estimates on the reference dissociation cons-
tants, and some of the free energies of binding might have been
previously predicted in some fashion (see below).
A generative model of binding energy
It is reasonable to expect that in many cases the accuracy of
estimating the frequency of the ds-oligos in the bound solution will
be low (due to low counts). The accuracy of many of the calculated
Ki
D may also be low because they are much smaller than ½TF , and
therefore the probability of binding is close to 1.0 (see Equation 2).
The accuracy of the Ki
D estimates will also be low if the Ki
D are
much greater than ½TF , and therefore the probability of binding is
closetozero.Onepotentialwaytoimprovethesituationistobuilda
generative model of binding energies. It is also of general interest to
better understand how binding energies are formed based on
independent position effects and interactions among positions.
The general model we will consider to generate an energy-based
DGE
i for a specific sequence Si (Figure 2) includes positional
energy terms relative to the optimal binding energy (DGE
opt); these
positional terms are independent (el
i) or interactive (e.g., e
m,n
i ), and
the energy is given by:
DGi&DGE
i zei~DGE
optz
X L
l~1
el
iz
X L{1
m~1
X L
n~mz1
e
m,n
i z:::zei: ð7Þ
Here, el
i is an abbreviated way of indicating the position l-specific
energy of the specific nucleotide (G, A, C, or T) that is found at
position l in sequence Si. The independent position-specific energy
terms are all zero (for the optimal sequence) or positive (since no
sequence-specific binding energies can be lower than the opti-
mum), and there are therefore up to 3L different independent
energy term parameters. The abbreviation is similar for the pair-
wise terms, and the ellipses indicate the possibility of higher-order
energy terms, although these were not implemented here. The
interactive energy terms would be presumed to be zero unless
otherwise justified, and constrained such that no sequence has a
lower energy than DGE
opt. We use an indicator matrix, I, that
controls the inclusion of individual energy terms in the model
according to their posterior justification using a reversible jump
Markov Chain (discussed in more detail below). We note that in
the current implementation, the prior is uniform on each possible
model. This may be more rigid than is desirable, and it may be a
productive area for future research to consider other parameters,
for example by including a hyperparameter on the probability that
individual energy terms should be included.
In the examples here, we also include a random variable term,
ei, which allows for possible sequence-specific error in the gener-
ative energy model. Because the individual sequence-specific esti-
mates are included as part of the GEM, this error term allows an
automatic transition from the energy model predictions to the
BBM predictions if the GEM is inaccurate or if the pre-bound and
bound counts are especially accurate for a particular sequence.
This variable is modeled as a normal distribution centered around
zero and with variance s2
E. This is equivalent to stating that for the
generative energy model (GEM),
DGi*N(DGE
i ,s2
E): ð8Þ
Thus, s2
E is a free parameter in the model that determines how
much the GEM controls the range of credible sequence-specific
energies (as opposed to control based on the observed sequence
frequencies in the two solutions). We note that if only the additive
portion of this model were used, the result would be similar to
PWM scores only under the additional constraint of very low
concentration of transcription factor [47,52]. The log of the
likelihood, P(Djh), in the GEM is thus calculated as
logL~log
X n
i
ci!
 !
z
X n
i
ci! ðÞ log v0
i
  
{log ci! ðÞ z
log
X
i
bi!
 !
z
X n
i
bi log vb
i
  
{log bi! ðÞ {
log sE
ﬃﬃﬃﬃﬃﬃ
2p
p   
{
DGi{DGE
i
   2
2s2
E
:
ð10Þ
Figure 2. Graphical representation of the generative energy
model (GEM). As in Figure 1, unobserved variables (i.e., parameters
I,E ,DG, DGE, DGE
opt, sE and KD) are in hollow circles, and probabi-
listic dependencies and their directions are shown with solid arrows,
while deterministic dependencies are shown with dashed arrows. The
Basic Binding Model (Figure 1) is linked as shown. As in Figure 1, the
free parameters (E, DG, DGE
opt, and sE) are shown with thick-bordered
circles, as is the model indicator matrix, I. The dependent parameters
calculated from the free parameters in the GEM are (DGE, and KD), and
the other parameters (not shown) are the same as described in Figure 1.
doi:10.1371/journal.pone.0026105.g002
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0 and DG are still freely
variable in the GEM. There are, however, two new free para-
meters in the GEM, s2
E and DGE
opt, along with the new set of free
energy parameters, E, and the freely variable indicator matrix I
that controls inclusion of the various energy parameters in the
family of GEM models. The dependent vb
i parameters in the
likelihood calculations for the GEM model (Equation 10) are thus
calculated using these new free parameters as well.
A generative sequence model
In many instances, an experiment may be run in which there
are too many ds-oligos synthesized relative to the amount of
sequencing carried out, so that the accuracy of estimating the
frequency of the ds-oligos in the pre-bound solution is low. In such
instances, it may be advisable to build a Markov model of ds-oligo
synthesis based on dinucleotide or higher polynucleotide observed
frequencies in the pre-bound ds-oligo mix. We used a simple
generative sequence model (GSM) whereby, if the ds-oligo was of
length L and the polynucleotide size was length K, the GSM-
predicted count, cGSM
i , for a particular ds-oligo sequence Si was
cGSM
i ~nC   p0
i P
L
k~Kz1
p ak
i jPk{1
i
  
, ð11Þ
where p0
i is the probability (in the entire data set) that a ds-oligo
will start with the polynucleotide of length K observed at the start
of Si, ak
i is the nucleotide observed at position k in Si, Pk{1
i is the
polynucleotide P of length K ending at position k{1 in Si, and
p ak
i jPk{1
i
  
is the probability of ak
i being observed in the data
immefodiately following the observation of Pk{1
i . As before,
nC~
P
i
ci is the sum frequency of all observed full-length ds-oligo
counts in the pre-bound fraction. The frequency p0
i is included to
take into account any beginning terminus bias in the sequence
generation probabilities. The graphical representation of this
model (Figure 3) therefore contains two input vectors that
determine the sequence: the set of frequencies for all polynucle-
otides of length K at the starting position P0~ p0   
; and
PA,K~ p akjPk{1      
, the set of probabilities for each nucleotide
given that it is preceded by a particular polynucleotide of length K.
We note that we are treating these frequencies here as highly ac-
curate estimates and not accounting for uncertainty in the esti-
mates; the uncertainty should be negligible as long as K is small
enough that the number of possible polynucleotides is much less
than the total ds-oligo counts (i.e., K4vvnC). As will be clear in
the results section, we did not utilize this model in any likelihood
analyses in the current study based on our estimate of the lack of
applicability of the model to current datasets. Instead, we evalu-
ated the predictive utility of the model and used it to generate
sequences for simulation of a full SULDEX study. However, the
SULDEX program is designed to use C
GSM in place of C as
needed, or in place of V
0 directly (foregoing the multinomial and
not treating the v0
i as free parameters) if C
GSM is believed to have
negligible error.
Markov chain Monte Carlo estimation
MCMC runs used the Metropolis-Hastings algorithm [53]
acceptance ratio:
a(h,h
0)~min 1,
p(h’jD)p(h’)q(h
0,h)
p(hjD)p(h)q(h,h
0)
  
, ð13Þ
where q(h
x,h
y) is the proposal density, or the probability of
proposing a move to parameter set h
y given a current state of h
x.
Symmetric (Gaussian) proposals were used throughout, so that the
proposal ratios always cancelled out. Flat, non-informative priors
were also used throughout, making the prior ratio also cancel. The
acceptance ratio was therefore simply the ratio of likelihoods
between the current and proposed parameter states, thus making
the posterior distribution equivalent to the likelihood surface.
Proposal widths were tuned prior to each analysis, yielding an
acceptance ratio close to the optimal value of 0.45 for
unidimensional proposals [54] or around 0.234 for multidimen-
sional proposals [55]. Analyses were run several times so that the
ratio of within- to between-chain variances could be used to
measure convergence (although in practice, running chains for
100,000 generations and excluding the first 10,000 as burn-in was
generally adequate).
Reversible jumps in model space
In GEMs, site-specific energy terms are set to zero (that is, they
do not modify the optimum position-specific energy) unless there is
strong evidence that a particular nucleotide at a position makes the
binding worse. The vector of all energy terms is E~ el
i,e
m,n
i
  
.I ti s
clear that only a limited number of interactive energy terms may
be used in conjunction with the additive energy terms in order to
avoid problems with non-identifiability of parameters. Here, we
consider only the usage of the additive energy terms, and constrain
all interactive energy terms to be zero. We also use an indicator
matrix, I, which tracks whether an element of E is constrained to
equal zero in the current state of the model. When implementing
the energy model, energy terms are added or removed (made
equal to zero) using Green’s reversible jump MCMC (RJMCMC)
approach [56], which is generally used to switch between
parameter spaces with different dimension sizes. All dimensional
jumps increase or decrease the number of terms in E (and thus the
dimension of the parameter space) by one, and these moves begin
by either randomly sampling the value of a new energy term from
a uniform distribution from 0 to width w, e’*U(0,w),o r
collapsing an energy parameter term to zero. However, since
these proposals may not be good samples near the optimum for the
new dimension, we use a technique called ‘‘proposal reallocation’’
[57], in which we perform k fixed-dimension MCMC steps
Figure 3. Graphical representation of the generative sequence
model GSM. Symbols and arrows are as in Figure 1. The pre-bound
counts, CK, are given a superscript K to indicate that they are counts
for the shorter ds-oligos need for the GSM of size K. The parameter set
includes the various polynucleotide probabilities used in the GSM
(P0 and PA,K) as well as the new predicted counts, C
GSM
i . In the
SULDEX program, the GSM can be linked to the BBM (Figure 1) using
C
GSM
i in place of C or V
0, although that was not done in the analyses
presented here due to problems with the available datasets.
doi:10.1371/journal.pone.0026105.g003
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1,h
2,:::,h
k) satisfying detailed balance
with respect to p(Djh)p h ðÞ . The final state h
k is then used for the
decision to accept or reject the move to the new dimensional
space, and we use a k that is large enough (based on empirical
tests) that q(h
x,h
y) is assumed to be independent of h
x, i.e., that
q(h
x,h
y)*p(Djh
y)p h
y ðÞ . Note that we are thereby essentially
using an arbitrary implicit prior ratio of 1:1 for the two
hypotheses, and that the ratio of time spent in any two adjacent
dimensional spaces will be equal to the Bayes Factor between
those spaces.
Accuracy of the generative sequence model
For a given dataset, we evaluated the accuracy of the GSM for
each polynucleotide of length K and ds-oligo length L by com-
paring its predictions for frequencies of each ds-oligo i (  v vGSM
i,K,L)t o
their observed values. The observed values can be considered
precise estimators for comparison (i.e., v0
i,L&^ v v0
i,L) only in cases
where the ds-oligos all have high counts, and in practice we could
not go above ds-oligo length 7 for the GSM accuracy analysis. To
evaluate estimator accuracy we used the root mean square error
(RMSE), where RMSEK,L~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P
i
  v vGSM
i,K,L{^ v v0
i,L
   2
s
, which in-
cludes both bias and variance in the estimates as they deviate
from the true value.
SULDEX Simulations using existing control data sets
Two existing sets of data containing moderate numbers of KDs
were used for simulation analyses, 43 Leu3 [26], and 46 ArcA
binding sites [28], with two reference sequences chosen for each
data set. We also used the Zif268 Bind-n-Seq data (at 5 nM initial
transcription factor concentration), including only the 436 ds-oligos
that were within two nucleotide differences from the consensus
binding site (GCGTGGGCGT). We used the top three best binders
(GCGTGGGCGG and GCGTGGGAGG and the consensus) as
reference KDs (0.25728988, 0.579150579, and 0.15026296 nM,
respectively). To determine the effectiveness of the SULDEX
procedure in obtaining accurate dissociation constants and energy
models, datasets were simulated based on known (or presumed)
dissociation constants, mimicking the steps in a real SULDEX
experiment. For simulations of the Leu3 and ArcA data, sequences
were generated at equal frequencies. To avoid expected generation
frequencies of zero for the Zif268 sequences, they were generated at
frequencies equal to 0.8 times the observed frequency plus 0.2 times
the frequencies obtained from a GSM with polynucleotide length 7.
The accuracy of parameter estimates (^ K Ki
D) from the posterior means
were then evaluated using the root mean square error (RMSE) of
their logs,RMSE~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ ﬃ P
i
ln ^ K Ki
D{lnKi
D
   2
r
. The protein concentra-
tion and the total copy number were varied in these simulations to
determine what effect these experimental conditions have on the
accuracy of the outcomes, and thus to guide experimental design.
For the Leu3 and ArcA data, each ½TF  was categorized into low,
medium, and high when its value was, respectively, lower than the
lowest KD, close to the lowest KD, or in the middle of KD
distributions of the target sequences.
Results
In this study, we introduce multiple models for use in analyzing
the results from SULDEX experiments. The first is the basic
binding model (BBM), which can be used in situations where
enough data has been collected such that most ds-oligo counts in
the pre-bound and bound fractions are large enough to allow their
frequencies to be estimated fairly accurately. We fit this model
with the likelihood function given in Equation 6. The other two
model classes are designed as extensions of the BBM. The gener-
ative sequence model (GSM) is designed to provide replacement
estimates of counts in situations where many (or most) of the
observed counts in the pre-bound fraction are zero or so small that
they are estimated poorly. Such situations typically occur when
there are exceptionally large numbers of sequences (e.g., 410 or 420
for length 10 or 20 random ds-oligos, respectively). As described
below, however, we find that for available large-scale datasets
neither the original counts nor this model are adequate, and so the
GSM (Equation 11) was used only to generate synthetic datasets
for testing the effectiveness of Bayesian analysis in determining
parameters for the other models. Finally, we introduce the gener-
ative energy model (GEM) to provide better estimates in situations
where some or many of the bound counts are not accurately
determined. The GEM is actually not a single model, but a family
of models in which various free energy parameter terms are turned
on and off (included or removed from the model) during the course
of the reversible jump Markov chain Monte Carlo analysis. We fit
this model with the likelihood function given in Equation 10. The
SULDEX program for implementing these analyses is freely avail-
able at the authors’ web site, www.EvolutionaryGenomics.com.
We begin the results with an analysis of experimental design con-
siderations and the effectiveness of the GSM, followed by imple-
mentation and testing of the BBM and GEM on the small Leu3
and ArcA datasets, followed by testing of a full GEM-based
SULDEX analysis of 10 mers simulated based on GSM count
predictions from the Zif268 Bind-n-Seq 20 mer dataset.
Experimental Design
An important consideration for experimental design is the syn-
thesis of the ds-oligos that will be made into double-stranded
targets and then bound to a transcription factor. This leads to
several questions: What is the preferable target structure? What
should the relative frequencies of different ds-oligos be? and what
part of the binding site should be targeted with variation? SUL-
DEX ds-oligos may contain primer regions for sequencing, vari-
able sequence tags (or ‘‘barcodes’’) to distinguish different experi-
ments, and variable (experimental) and constant parts in the
binding site and flanking region to prevent differential binding
depending on which sequence tag is used. There is an inherent
tradeoff between the goal of analyzing many sequences at once
and the goal of obtaining accurate results. As accurate estimation
of dissociation constants depends on accurate estimation of the
pre-bound target frequencies, for a given number of sequence
counts, including more ds-oligos in an experiment will lower the
average number of sequence counts per ds-oligo. Furthermore,
when many ds-oligos are included in the mixture, the variation in
realized ds-oligo concentrations will mean that some ds-oligos are
at much lower concentrations compared to others. For example, in
the Zif268 data [12], hexamer (length 6) counts vary by 384 fold.
In the HT-SELEX data [13], the expected ratio between the
highest and lowest count 10 mer ds-oligo is over 1 billion.
This simple result has serious implications for designing experi-
ments with satisfactory accuracy. One way to address this is to
limit the number of ds-oligos per experiment. We can consider
that if each ds-oligo we care about is sequenced 100 times in the
pre-bound fraction, the standard deviation (std) of the count is
10% of its expectation (according to a Poisson assumption). Thus,
we might want to sequence such ds-oligos 100–1000 times. It may
be currently reasonable to expect 65 million reads in a single lane
of Illumina HiSeq sequencing, meaning that one could reasonably
target 65,000 different ds-oligos, hoping that with an average
expectation of 1000 counts, a large fraction would be sequenced
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sites should be varied (leading to 65,536 different ds-oligos). Al-
though this may work for some studies, it may be unsatisfactory for
others, and we suggest two alternatives to allow the entire binding
site sequence repertoire to be evaluated at once. The first sugges-
tion is to make smaller numbers of variants, and then mix them.
For example, if five sites at a time were randomized in a 10 mer,
and this was repeated 15 times over with a careful assortment of
sites each time, then all pairwise deviations from the consensus
sequence might be reasonably sampled in the mixture of these 15
syntheses containing 15,360 different ds-oligos. The second sug-
gestion is to synthesize 50:50 nucleotide mixtures at each site,
focusing on those variants at each site that are thought to be
relevant to binding the transcription factor in question. This is
similar to a previously proposed approach for sampling ancestral
sequences [58].
In cases where there are too many variants to get accurate
relative frequencies in the pre-bound fraction, it is possible to use a
predictive model. A simple model is to use the mononucleotide
frequencies to predict ds-oligo frequencies, assuming that there is
no higher-order interactive effect, as in [13]. A preliminary
analysis of the Bind-n-Seq data [12] indicated that this simple
model was not satisfactory, as demonstrated by the observation
that the frequencies of many ds-oligos are substantially different
depending on which direction they are considered. This is also
true of the HT-SELEX data. We therefore developed an order
and context-dependent generative sequence model (GSM) to in-
clude higher-order interactions using polynucleotides of varying
length to predict subsequent sequences (see Methods).
It is straightforward to test the predictive accuracy of this GSM
on shorter ds-oligos since the frequencies of short ds-oligos can be
accurately measured by direct count. For the Bind-n-Seq data
[12], the average predicted error for counts of 5 mer sequences is
1.96%, which is accurate enough to compare to GSM estimates.
Using the observed values as a reference, the GSM with polynu-
cleotide lengths of 1, 2, and 3 had RMSEs of 71.1%, 40.5%, and
22.1%, respectively. This indicates strongly that GSMs with longer
polynucleotide dependencies are preferable, and thus that the
longest polynucleotide that can be accurately measured (based on
the predicted accuracy of the observed polynucleotide frequencies
in a dataset) should be used. Although these predicted error rates
are somewhat disappointing, the errors in predictions of 10 mer
frequencies are likely to be considerably higher. Our sense is that
there are other more complex trends in the data that may allow
greater predictive accuracy, but that a greater number of indepen-
dent synthesis datasets are required to determine if these trends are
general and thus worth computationally pursuing.
The second step in SULDEX is to incubate the ds-oligo mixture
with a transcription factor of interest. The concentration of free
transcription factor in solution is the most important consideration
in determining the outcome of the experiments (i.e., the accuracy
of estimating binding energies or dissociation constants of interest).
Unfortunately, this is difficult to predict ahead of time, as it
depends on the concentrations and binding energies of all the
sequences in solution, which are of course unknown at the outset.
In cases where most of the sequences in the mixture are of interest
(i.e., if variation in the mixture is targeted to be similar to the
known binding motif), one can simply add different amounts of
protein (holding the amount of sequence mixture constant), and
from EMSA estimate the total ds-oligo content in the unbound
and bound regions of tthe electrophoretic gel. An intermediate
starting protein concentration can then be chosen in which
approximately half of the DNA is in the bound fraction. Another
possibility is to co-immunoprecipitate sequences bound to a
transcription factor to measure the relative frequencies of the
reference sequences in the pre-bound and bound solutions using
quantitative PCR [59] or high-throughput sequencing.
Analysis of the generative energy model with Leu3 and
ArcA data
To demonstrate the utility of the GEM analyses, we simulated
SULDEX sequencing experiments using pre-existing datasets of
known dissociation constants for the transcription factors Leu3
and ArcA. Since the original data sets include dissociation
constants for less than 50 distinct sequences, we could not
generate enough information to evaluate interaction terms.
Therefore, only independent position-specific (additive) energy
components were included in analyzing these simulations. In
general, it is unclear how accurately a simple additive GEM will
estimate binding energies. As described below, additive GEMs
estimated from the ArcA dataset predicted binding energies
extremely well, although this was not true for the Leu3 dataset.
The point of the GEM is to leverage the information about
binding energies in the data set as a whole, to improve binding
energy predictions for individual ds-oligos. If the GEM accurately
represents the determinants of binding energy, then less sequenc-
ing may be required to achieve good results. An accurate GEM
will therefore be particularly helpful for predicting binding
energies for ds-oligos that are sequenced at low frequency, or that
bind poorly, and are thus under-represented in the data. This
insight motivated the inclusion of an error term (s2
E) to account for
inaccuracies in the energy model (see Methods). This error term is
estimated along with the rest of the model, allowing an automatic
transition from the energy model predictions to the basic binding
model predictions when either the GEM is inaccurate or when
large pre-bound and bound counts allow KDs to be accurately
predicted by the BBM alone. When the counts get large, the model
effectively factors apart into two subcomponents: a multinomial
model in which all dissociation constants are entirely determined
by the pre- and post-binding counts (and the reference dissociation
constants), and an energy model that attempts to reproduce those
nearly-certain dissociation constants in terms of a combination of
energy parameters and error terms.
As expected, binding predictions were more accurate (had lower
log KD RMSEs) as the average number of sequence counts was
increased (Figure 4). The results for Leu3 GEM analyses indicate
that the error term improved predictions, since the RMSEs are
mostly well below the value obtained when the error term was
excluded (0.4). Although the GEM analytical predictions are not
quite as accurate as the BBM predictions for Leu3, the error term
allows the GEM to mostly reflect the accuracy inherent in the high
counts and not the less accurate predictions of the energy model.
For the experiments with Leu3 at a concentration of 50 nM, for
which the BBM had the lowest accuracy among the Leu3 runs,
there are some conditions for which the GEM analyses had slightly
less error than the BBM analyses alone (Figure 4). Under these
conditions (the highest transcription factor concentrations), many
of the strong and moderate binders are almost completely bound
(not shown), and it is therefore hard for the BBM to accurately
distinguish the relative magnitude of their dissociation constants.
For the ArcA data, the GEM provides an improvement over the
BBM in almost all cases. While the BBM RMSEs get substantially
worse when the free transcription factor is high (Figure 4; note the
differing scales on the graphs), the GEM RMSEs are similar for all
but the lowest counts. The difference between the two methods is
most notable in the results for the 1 mM (1000 nM) concentration
of transcription factor. Evaluation of the errors as a function of KD
(Figures S1a and S2a) indicate that most of the error reductions
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where they are poorly estimated by the BBM. It is also worth
noting that for ArcA, with its relatively accurate GEM, increases in
the amount of sequencing only slightly alter the RMSEs under the
GEM, and the variance of the error estimates are slightly narrower
(Figure S2b). In contrast, the error terms for the Leu3 GEMs
become considerably larger with increases in the amount of total
sequence counts collected (Figure S1b). One way to view this is
that as more counts accumulate, the BBM estimators become
more accurate and thereby better expose the inaccuracy of the
Leu3 GEM estimates. Thus, the change in the error estimate with
increased sequencing seems to serve as an indicator of the reli-
ability of the GEM.
Relationship between posterior energy model terms and
binding site consensus
Leu3 binds to a palindromic consensus site (CCGgtacCGG) as a
homodimer to regulate genes involved in branched-chain amino
acid metabolism [60]. There are 10 positions in the palindromic
binding site, but since only 43 variants with known dissociation
constants were available for the simulation analysis, there is a great
deal of missing data. Positions 2 and 9, for example, do not vary,
and there are only two variants each at positions 3, 8 and 10. In
the original experiment [26], variants with mutations at positions 2
and 9 were too deleterious to Leu3 binding to be observed. An
examination of the posterior mean binding energy estimates for
the intermediate binding conditions ( TF ½  =10 nM) and moderate
counts (average 10 per ds-oligo) indicates that a number of
positions have only marginal differences between the optimal
variant and the next-best variant (Table 1). At position 3, for
example, the mean posterior position-specific energy difference
between G and T is only 0.03 energy units, and at position 7 the
difference between C and T is only 0.04. In contrast, the nucle-
otide T at position 1 is the most deleterious variant, with 1.9
Figure 4. Comparison of the Basic Binding Model (BBM) and Generative Energy Model (GEM). The BBM results are shown in blue, and the
GEM results in red. Data were synthesized based on the Leu3 (a) and ArcA (b) dissociation constant data sets. In silico sequences were equilibrated,
resulting in 1 nM, 10 nM, or 50 nM free ½TF  for Leu3, and 1 nM, 100 nM, or 1000 nM for ArcA. Values are the RMSE across all log KD estimates, and
error bars shown are for four replicates. Average reads (counts) per ds-oligo sequence ranged from 1 to 100.
doi:10.1371/journal.pone.0026105.g004
Table 1. Posterior distribution of position-specific energy
terms for Leu3, ½TF =10 nM, average counts=10).
ACGT
Position mean std mean std mean std mean std
1- - 0.00* 0.01 0.32 0.21 1.88 0.46
2- - 0.00* 0.00 -- --
3- - - - 0.02* 0.05 0.05 0.10
4 0.91 0.45 0.15 0.19 0.04* 0.10 0.19 0.22
5 0.42 0.15 0.58 0.20 0.80 0.26 0.00* 0.01
6 0.01* 0.03 1.22 0.30 0.33 0.36 0.61 0.18
7 0.57 0.25 0.25* 0.16 0.71 0.51 0.29 0.47
8 0.28 0.27 0.02* 0.07 -- --
9- - - - 0.00* 0.00 --
10 - - 0.92 0.35 0.00* 0.01 --
The lowest energy term at each position is in boldface, and the mean for the
consensus sequence is indicated with a *. Variants that were not tested in the
analysis have a dash.
doi:10.1371/journal.pone.0026105.t001
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nucleotide at this position.
One of the features of our modeling approach is that Markov
chains are run over different models that include varying numbers
of parameters. For example, an energy term might not be required
if the corresponding variant is energetically indistinguishable from
the optimal binding variant. In general for Leu3, a mean posterior
energy difference of about 0.6 or greater is associated with a
posterior probability of .0.95 that an energy term is required (i.e.,
that having that nucleotide at that position worsens the energy of
Leu3 binding enough that an energy term is required to dis-
tinguish it from the optimal variant; Figure 5). As expected, the
lowest energy terms at each position generally match the con-
sensus (Table 1).
ArcA binds as a symmetric dimer to a tandem-repeated 15-
position consensus site (GTTAccattATGTTA) to regulate genes
involved in oxygen response [28]. There were 46 sequences
available with known dissociation constants, and out of the 136
possible single nucleotide variants, only four were not represented
in these 46 sequences (Table 2). Results (Table 2 and Figure 5)
are similar to those from Leu3, with the lowest energy variant
usually matching the consensus, with some variants only slightly
different from the lowest energy variant (e.g., C versus G at
position 6), and with some variants being extremely deleterious
(e.g., C at position 1).
Simulating a more complete SULDEX experiment
A more complete SULDEX experiment would include most or
all of the ds-oligos that are likely to be specifically bound by a
transcription factor, unlike for the Leu3 and ArcA data sets, which
each have dissociation constants for fewer than 50 binding sites.
Furthermore, for the Leu3 and ArcA simulations we assumed
equal pre-bound frequencies, even though it is more realistic to
expect variation in the relative frequencies of the different ds-oligos
in the pre-bound fraction. We therefore tested our method on a
more complete SULDEX experiment simulation that incorporat-
ed these factors. The best available dataset for this purpose, that
we are aware of, is the Zif268 data from the Bind-n-Seq experi-
ment [12]. The Bind-n-Seq dataset, however, presents a major
practical difficulty in that the Zif268 binding sites (length 10) are
located within random 21 mers, meaning that the local context for
any putative binding site varies in every instance. The efficiency of
ds-oligo synthesis itself can vary with local sequence context, some-
times resulting in dramatically unequal frequencies (as discussed
above). Additionally, the probability that a target site is bound may
vary with sequence context, and the transcription factor may even
bind to different locations on a long ds-oligo. Thus, the probability
of binding a sequence must be summed over all binding locations,
and 10 mer frequency distributions may not directly reflect bind-
ing probabilities due to interference caused by binding at other
locations. Because of these problems, one cannot expect that the
true Zif268 dissociation constants values can necessarily be accur-
ately determined from this dataset. Nevertheless, SULDEX ana-
lysis of these data can provide a large set of reasonable parameter
values for simulating a dataset for the purpose of testing the
method. We therefore performed such an analysis, and then
simulated binding using the ‘‘known’’ dissociation constant values.
The first step of the simulation is the synthesis of pre-bound
10 mers at different background frequencies. Some of the frequen-
Figure 5. Posterior probability of position-specific energy terms in Leu3 and ArcA. The posterior probability for each nucleotide at each
position is shown in the order A (black), C (red), G (green), and T (blue). Gray dots are shown for nucleotides for which no information was available in
the data, and black dots are shown over the nucleotide used at a site where no variation was available at that site. The consensus sequence is shown
above the probability bar corresponding to the consensus nucleotide. Capital letters indicate a strongly preferred consensus nucleotide at a position,
while lower case letters indicate a more indeterminate consensus nucleotide. Conditions are specified in Tables 1 and 2.
doi:10.1371/journal.pone.0026105.g005
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bound counts in the Zif268 dataset were low or zero. We therefore
generated pre-bound sequences using a generative model (GSM;
see Methods), which predicts frequencies for all ds-oligos. The next
step is to simulate binding of the 10 mers according to their
‘‘known’’ binding affinities based on energy terms derived from the
preliminary SULDEX analysis of the Zif268 data. For results
below, we synthesized and analyzed 10 mers differing from the
consensus by two nucleotides or fewer. Simulations were run
at four transcription factor concentrations (0.1, 1.0, 10.0, and
100.0 nM) with an average of 1000, 200, 100, or 20 sequence
reads per ds-oligo in the pre-bound and/or bound solutions.
Bound frequencies were obtained by multiplying the pre-bound
frequency by the probability of binding calculated as in Equation
2, using the GEM to obtain the binding energies and thus the KDs.
Simulations were replicated three times for each condition to
obtain means and variance of all estimators, and were evaluated
using the basic method alone (BBM), and using the basic plus
GEM method, both including three known reference KDs.
In the MCMC analysis, pre-bound frequencies and ½TF were
treated as free parameters (subject to the constraints of the model)
and posterior estimates of all parameters were compared to their
true (simulated) values. When an average of 1000 sequence reads
(counts) per ds-oligo were used, the mean KD estimators for both
models were generally accurate for a variety of transcription factor
concentrations (Figure 6). One caveat is that the basic binding
model required inclusion of a reference ds-oligo with high KD
(100 nM) to obtain remotely accurate KD estimates when the
transcription factor concentration was high (½TF =100 nM). In
contrast, the energy model does not, and even the very lowest KDs
are estimated poorly (Figure 6a, ½TF =100 nM). Furthermore,
the KD estimates were slightly worse for the basic binding method
at the lowest and highest transcription factor concentrations. The
transcription factor concentration estimates were accurate as well
(data not shown). In general, the individual KD estimates were
worst for ds-oligos that have very low counts in the pre-bound
and/or bound fractions.
As described in the previous section, the energy model is ex-
pected to provide a greater benefit when more counts in the pre-
bound or bound fraction are low. This prediction is borne out by
the simulations with reduced sequencing per ds-oligo (Figure 7 and
8). The GEM has better accuracy, particularly for ds-oligos with
high KD values (Figure 9), indicating that it provides a better
estimator by sharing information across sequences according to
the GEM. The effect is even more pronounced when the pre-
bound ds-oligos are sequenced in higher numbers, but the bound
ds-oligos are not. The GEM energy terms themselves are also
estimated accurately as long as the pre-bound sequencing is high
(Figure 10), although some of the largest energy terms are esti-
mated less accurately than the others. This is to be expected, since
the high-energy terms lead to ds-oligos with weak binding proper-
ties for which the strength of binding can only be approximately
estimated.
Discussion
The core principle applied in this study is that in solution and at
equilibrium, the proportion of a particular TFBS sequence that is
bound to a transcription factor (the probability of binding) is
determined by the dissociation constant between the sequence and
transcription factor, and the concentration of free transcription
factor. Therefore, if one knows the relative frequencies of different
sequences in a mixture prior to binding, one can predict the re-
lative frequencies of those sequences that are bound to the tran-
scription factor. A difficulty arises, in that the free concentration of
transcription factor is generally unknown, and if the equilibrium
constants are also unknown then there are more unknowns than
data points (i.e., ds-oligo sequence counts in the bound solution).
This problem can be easily solved by including at least two
reference sequences with known dissociation constants in the basic
(BBM) system, and if an energy model (GEM) is used, only one
reference sequence is required. To ensure accuracy, it is also best if
the counts for the reference sequences are relatively high. Al-
though one could first solve for the unknowns using the reference
sequence data, we have chosen to use a flexible Bayesian approach
that can account for errors and uncertainty in all data points and
allows inclusion of as many reference sequences as are available.
One of the main benefits of the Bayesian approach is that it can
incorporate information from multiple sources, all with varying
degrees of uncertainty. In the simple graphical system that does
not model the binding energy (Figure 1), the sources of infor-
mation are the counts of sequences before the transcription factor
is bound (C) and the counts in the fraction bound to the trans-
cription factor (B). It is assumed that these counts are random
draws from a multinomial based on the true underlying pro-
portions of the sequences in the two solutions, respectively V
0 and
V
b. These counts thus constrain the reasonable range of values for
the underlying proportions, with higher counts constraining the
proportions more than lower counts. The ds-oligo proportions in
the bound solution containing transcription factor are modified
from the pre-bound proportions based on the sequence-specific
probability of binding the transcription factor. The reference
sequences, with known dissociation constants, allow the informa-
tion about the proportions of sequences in the two solutions to be
translated back into information about the dissociation constants,
and thus the binding energy of each sequence i through the
relationship DGi~RT lnKi
D (see Methods for details). Inclusion of
at least two reference sequences ensures the identifiability of all
unknown parameters.
Table 2. Posterior distribution of position-specific energy
terms for ArcA, ½TF =100 nM, average counts=20).
AC G T
Position mean std mean std mean std mean std
1 1.42 0.31 2.32 0.19 0.00 0.00 1.05 0.28
2 1.49 0.32 2.11 0.46 - - 0.00 0.00
3 0.52 0.31 2.18 0.51 0.46 0.29 0.00 0.02
4 0.00 0.01 2.27 0.43 0.74 0.30 1.74 0.39
5 0.25 0.20 0.01 0.05 0.77 0.36 0.40 0.35
6 0.35 0.14 0.06 0.13 0.13 0.18 0.32 0.28
7 0.09 0.15 0.22 0.24 0.12 0.18 0.51 0.09
8 0.24 0.19 0.17 0.23 0.51 0.33 0.03 0.08
9 0.07 0.10 0.19 0.22 0.21 0.22 0.05 0.10
10 0.02 0.06 0.64 0.32 0.53 0.32 0.27 0.14
11 1.02 0.27 0.66 0.33 1.02 0.30 0.01 0.05
12 - - - - 0.00 0.00 --
13 2.24 0.51 1.72 0.37 2.08 0.41 0.00 0.00
14 0.10 0.15 1.83 0.39 0.16 0.20 0.03 0.06
15 0.00 0.01 1.70 0.40 0.75 0.31 1.13 0.32
Notation is the same as in Table 1.
doi:10.1371/journal.pone.0026105.t002
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for a single representative simulation replicate for each condition. In these simulations, there were 1000 counts per ds-oligo on average in both the
pre-bound and bound solutions, and ½TF  was 0.1, 1.0, 10, or 100 nM. For the Basic (BBM) model (a), but not the GEM (b) model, a reference ds-oligo
with a larger KD was required for ½TF =100 nm (c.f., Figure S1). Only the 89 high affinity ds-oligos with KDv200 nM are shown (out of 436 total ds-
oligos).
doi:10.1371/journal.pone.0026105.g006
Figure 7. Accuracy of Zif268 KD estimates with fewer counts in both solutions. Results are displayed as in Figure 6. The ½TF  was 1.0 nM
and there were 200, 100, or 20 sequence counts per ds-oligo in both the both the pre-bound and bound solutions (labeled as ‘‘pre-bound, bound’’ in
the different sub-figures).
doi:10.1371/journal.pone.0026105.g007
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PLoS ONE | www.plosone.org 11 November 2011 | Volume 6 | Issue 11 | e26105Figure 8. Accuracy of Zif268 KD estimates with fewer counts in bound solution only. Results are displayed as in Figure 6. The ½TF  was
1.0 nM, and there were 1000 counts per ds-oligo in the pre-bound solutions. There were 200, 100, or 20 sequence counts per ds-oligo in the bound
solutions. Pre-bound and bound solution concentration are labeled in the different sub-figures as in Figure 7.
doi:10.1371/journal.pone.0026105.g008
Figure 9. Relationship of BBM and GEM coefficients of variation for Zif268 simulations. Coefficients of variation (CVs, standard deviations
over the means) were calculated from the posteriors using the same data as shown in Figure 7. The dashed line indicates equal CVs for the BBM and
GEM estimators.
doi:10.1371/journal.pone.0026105.g009
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approach is our use of ‘‘generative energy models’’ (GEMs). With
these models, information is communicated across ds-oligo se-
quences to predict the binding energy. In GEMs, the binding
energy is considered to be composed of independent position-
specific energy components, as well as interaction energy com-
ponents [13]. The energy model may not be perfectly accurate,
however, and the error term for the energy model allows for
automated weighting of the accuracy of the energy-based pre-
dictions and the relative frequency-based predictions in coming to
a joint posterior prediction of each sequence-specific dissociation
constant. This weighting allows an easy switch from a basic
method that relies on reference ds-oligos with known KDs and the
counts alone, if they are high enough, to the GEM portion of the
model, if the error in the GEM portion is low enough.
There are similarities between the GEM and a position weight
matrix (PWM) model using binding energies since both are
(typically) estimated using independent energy contributions for
each position [40]. The main difference is that in PWM estima-
tion, the free TF concentration is assumed to be low. If this
assumption is inaccurate the PWM will return an incorrect energy
model. Therefore, an advantage of approaches such as ours that
allow ½TF  to vary, and to be estimated in the model-fitting process
(see also [13]), is that a more accurate energy model can be deter-
mined without restrictive assumptions. In addition, our method
also contrasts with PWM fitting in the use of reversible jumps
between models of different dimensions to allow simultaneous
estimates of the parameters of interest (the binding energies) while
only including those energy components that are statistically well-
justified.
We have also proposed a separate ‘‘generative sequence mo-
del’’, or GSM, which allows us to use the frequencies of shorter
sub-sequences (polynucleotides) to model the frequency of se-
quences in solution prior to binding. This is useful in cases (such as
the Zif268 Bind-n-Seq data) where there are so many pre-bound
sequences that most of them individually have extremely low
frequencies and are therefore difficult to count. For example, as we
showed for the Bind-n-Seq data [12], the relative frequencies of
their ‘‘randomly’’-generated ds-oligos of even 8 bp in length can
differ by many orders of magnitude. The range of frequencies for
longer ds-oligos is even greater, and thus if accuracy is a concern it
may be impossible to obtain sufficient coverage of all ds-oligos in a
highly complex mixture. The sequencing requirements for accur-
ate frequency estimates can easily be far beyond the capacity of
even the best modern high-throughput sequencers. The GSM
ameliorates this problem to some extent by providing improved
frequency estimators for ds-oligos with low sequence counts, and
may be further improved by discovering and incorporating other
general rules to predict frequency variation. In the meantime,
careful experimental design to reduce the number of sequences in
the mixture and focus on particular experimental questions is also
important if accuracy is a concern.
Two recently proposed approaches similar to the SULDEX
experimental system, Bind-n-Seq [12] and HT-SELEX [13], also
utilize ds-oligos sequenced before and after binding to a trans-
cription factor. The Bind-n-Seq analysis was designed to quali-
tatively identify binding site preferences, and assumes a simple
PWM model with no attempt to model the biophysical energy
terms or the relationship between the pre-bound and bound
solution counts. As we have noted here, the experimental results
are suboptimal for the purpose of measuring binding energies
primarily because binding sites are created randomly in the
varying context of a much longer random ds-oligonucleotide. This
variable context can affect the probability of ds-oligo synthesis and
Figure 10. Posterior estimates of nucleotide- and position-specific energy terms. The ½TF  was 1.0 nM, and counts per ds-oligo in the pre-
bound and bound solutions were 1000 and 1000, 100 and 100, or 1000 and 100, as labeled on the sub-figures. Results for nucleotide A, T, C, and G
energy terms at each position are color coded black, blue, red, and green, respectively. The mean posterior estimate is shown with a dot, the 95%
credible regions of the estimates are shown with vertical bars, and the true values are shown with horizontal bars.
doi:10.1371/journal.pone.0026105.g010
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The HT-SELEX approach, in contrast, has a similar aim to the
SULDEX approach, and uses the BEEML program to estimate
transcription factor concentrations and energy terms using a maxi-
mum likelihood approach and a nearly identical biophysical mo-
del. Key advantageous features of our approach include: 1) SUL-
DEX uses a Bayesian approach and MCMC rather than a maxi-
mum likelihood approach, resulting in posterior distributions and
an automatic estimate of uncertainty rather than only a point
estimate. Bayesian and MCMC approaches based on biophysical
models of transcription factor binding have previously been used
to analyze ChIP-chip or PBM data [48,61], and are particularly
useful for parameter-rich models such as these; 2) Unlike HT-
SELEX, SULDEX allows estimation of binding energies directly
from relative frequencies or in combination with an energy model,
and allows incorporation of reference sequences with known
binding energies. Thus, while both approaches include an energy
model error term, in SULDEX this term allows reduced depen-
dence on the energy model assumptions when binding energies are
inferred. Binding energy inference will flexibly depend more on
the energy model for low frequency ds-oligos with insufficient
sequencing to be estimated by the BBM approach alone; 3) SUL-
DEX uses the multinomial distribution to calculate the probabil-
ities of observed counts given underlying ds-oligo frequencies in
solution, while HT-SELEX’s BEEML program uses a Gaussian
approximation. This is most likely to matter when some counts are
small, which will often occur due to the high variance of starting
ds-oligo frequencies. BEEML also uses energy level discretization
to approximate the partition function; 4) We have presented here a
model (GSM) to predict relative ds-oligo frequencies in the pre-
bound fraction, and shown that the simple independent nucleotide
frequency model used in HT-SELEX/BEEML can be highly
inaccurate. The GSM should be further developed to increase
accuracy when data from a larger number of pre-bound ds-oligo
synthesis experiments become available; 5) the SULDEX method
allows simultaneous inference of model complexity and parameter
values by incorporating a reversible jump MCMC approach, thus
avoiding potential problems of model over-specification that can
lead maximum likelihood estimators (such as those in BEEML) to
focus on noise and thus reduce prediction accuracy.
We expect that a future application of this and related approa-
ches will be to allow detailed study of how binding energies are
influenced by nucleotide variation in the binding site. In parti-
cular, the simple additive energy model is insufficient to accurately
predict dissociation constants for many proteins, and interactive
energy terms will therefore be needed. The number of possible
interactive energy terms can be quite large, and their statistical
justification and usefulness should be carefully considered. The
reversible jump MCMC approach applied here can be used for
this purpose and allows detailed biophysical models to be deve-
loped, evaluated, and compared without making a large number of
assumptions. However, to explore interaction terms, it will be
important to implement careful experimental design for generat-
ing data. For the datasets currently available (Bind-n-Seq and HT-
SELEX), we do not believe that the pre-bound frequencies can be
reliably determined, and for the Bind-n-Seq data the binding
probabilities are confounded by variable context and possible
multiple binding opportunities per ds-oligo. Thus, it seems quite
possible that estimation of higher-order interactions in these
datasets could be thoroughly confounded by these other effects.
For example, in our own focused experiments using mitochondrial
transcription factor A protein (mtTFA; unpublished data), which
has moderate sequence specificity [62], we found that its multiple
binding modes and multimers that form on the ds-oligos, as well as
the context of varying sequence well outside the binding site, can
deeply confound interpretation. Experiments that therefore focus
on a sub-sample of possible ds-oligos close to the consensus or
optimal ds-oligo can produce precise estimates of binding energies
without relying on a model, and these may then be used to better
elucidate reasonable model structures.
Characterizing the binding potential of target binding sites for a
transcription factor within a species has immediate benefit for under-
standing transcriptional regulation for a particular system, but ap-
plyingthisstrategyacrossmultiplespeciesmayhavemorewidespread
impact. In particular, to understand morphological evolution, it is
necessary to have a clear idea of the relationship between trans-
cription factors, their strength of binding to a wide range of targets,
and how the binding energy relationships change as transcription
factors evolve. Future implementations can also include important
factors such as cooperative binding and interaction with repressors.
We therefore expect that exploiting methods for determining binding
energies across species will lead to substantial impact in other fields
and in understanding to approach questions relating to disease
pathology, evolutionary adaptation, and speciation.
Supporting Information
Figure S1 True versus predicted binding with and
without inclusion of an energy model for Leu3. The
relationship between the true and predicted log KDs are shown in
(a), with results that included the GEM model and an error term
shown with red circles, and results without an energy term (the
BBM model) with blue circles. The posterior distribution of the
respective error terms for the GEM model results are shown in (b).
Results are shown for free ½TF  of 10 nM (labeled a1 and a3, and
b1 and b3) or ½TF =50 nM (labeled a2 and a4, and b2 and b4).
Average counts per ds-oligo were also varied, with counts of 10 in
a1 and a3 (and b1 and b3), and counts of 100 in a2 and a4 (and b2
and b4). Dotted lines represent perfectly accurate KD predictions.
(PDF)
Figure S2 True versus predicted binding with and
without inclusion of an energy model for ArcA. Results
shown for ArcA are the same as for Leu3 in Figure S2, except that
free ½TF  was 100 nM or 1000 nM (1 mM).
(PDF)
Author Contributions
Performed the experiments: DDP APJdK HK. Analyzed the data: DDP
APJdK HK KK. Contributed reagents/materials/analysis tools: DDP
MEAC. Wrote the paper: DDP APJdK KJK. Conceived and designed the
study: DDP KJK TAC MEAC. Wrote novel programs to analyze the data:
APJdK HK. Revised the manuscript critically for important intellectual
content: DDP KJK TAC APJdK MEAC.
References
1. Carey M, Smale ST (1999) Transcriptional Regulation in Eukaryotes: Concepts,
Strategies, and Techniques. Cold Spring Harbor: Cold Spring Harbor
Laboratory.
2. Friberg MT (2007) Prediction of transcription factor binding sites using
ChIP-chip and phylogenetic footprinting data. J Bioinform Comput Biol 5:
105–116.
3. Reddy TE, DeLisi C, Shakhnovich BE (2007) Binding site graphs: a new graph
theoretical framework for prediction of transcription factor binding sites. PLoS
Comput Biol 3: e90.
4. Pape UJ, Grossmann S, Hammer S, Sperling S, Vingron M (2006) A new
statistical model to select target sequences bound by transcription factors.
Genome Inform 17: 134–140.
Bayesian Analysis of Protein-DNA Binding Affinity
PLoS ONE | www.plosone.org 14 November 2011 | Volume 6 | Issue 11 | e261055. Dai X, He J, Zhao X (2007) A new systematic computational approach to
predicting target genes of transcription factors. Nucleic Acids Res.
6. Chen Y, Blackwell TW, Chen J, Gao J, Lee AW, et al. (2007) Integration of
genome and chromatin structure with gene expression profiles to predict c-MYC
recognition site binding and function. PLoS Comput Biol 3: e63.
7. Ananko EA, Kondrakhin YV, Merkulova TI, Kolchanov NA (2007)
Recognition of interferon-inducible sites, promoters, and enhancers. BMC
Bioinformatics 8: 56.
8. Stepanova M, Lin F, Lin VC (2006) In silico modelling of hormone response
elements. BMC Bioinformatics 7 Suppl 4: S27.
9. Gibson G, Weir B (2005) The quantitative genetics of transcription. Trends
Genet 21: 616–623.
10. Carroll SBGJK, Weatherbee SD (2001) From DNA to Diversity: Molecular
Genetics and the Evolution of Animal Design. MaldenMA: Blackwell Science.
11. Maerkl SJ, Quake SR (2007) A systems approach to measuring the binding
energy landscapes of transcription factors. Science 315: 233–237.
12. Zykovich A, Korf I, Segal DJ (2009) Bind-n-Seq: high-throughput analysis of in
vitro protein-DNA interactions using massively parallel sequencing. Nucleic
Acids Res 37: e151.
13. Zhao Y, Granas D, Stormo GD (2009) Inferring binding energies from selected
binding sites. PLoS Comput Biol 5: e1000590.
14. Lassig M (2007) From biophysics to evolutionary genetics: statistical aspects of
gene regulation. BMC Bioinformatics 8 Suppl 6: S7.
15. Marcy Y, Ishoey T, Lasken RS, Stockwell TB, Walenz BP, et al. (2007)
Nanoliter reactors improve multiple displacement amplification of genomes from
single cells. PLoS Genet 3: 1702–1708.
16. Warren LA, Rossi DJ, Schiebinger GR, Weissman IL, Kim SK, et al. (2007)
Transcriptional instability is not a universal attribute of aging. Aging Cell 6:
775–782.
17. Marcy Y, Ouverney C, Bik EM, Losekann T, Ivanova N, et al. (2007) Dissecting
biological ‘‘dark matter’’ with single-cell genetic analysis of rare and uncultivated
TM7 microbes from the human mouth. Proc Natl Acad Sci U S A 104:
11889–11894.
18. Choi Y, Qin Y, Berger MF, Ballow DJ, Bulyk ML, et al. (2007) Microarray
analyses of newborn mouse ovaries lacking Nobox. Biol Reprod 77: 312–319.
19. McCord RP, Berger MF, Philippakis AA, Bulyk ML (2007) Inferring condition-
specific transcription factor function from DNA binding and gene expression
data. Mol Syst Biol 3: 100.
20. Bulyk ML (2007) Protein binding microarrays for the characterization of DNA-
protein interactions. Adv Biochem Eng Biotechnol 104: 65–85.
21. Berger MF, Philippakis AA, Qureshi AM, He FS, Estep PW, 3rd, et al. (2006)
Compact, universal DNA microarrays to comprehensively determine transcrip-
tion-factor binding site specificities. Nat Biotechnol 24: 1429–1435.
22. Bulyk ML (2006) Analysis of sequence specificities of DNA-binding proteins with
protein binding microarrays. Methods Enzymol 410: 279–299.
23. Berger MF, Bulyk ML (2006) Protein binding microarrays (PBMs) for rapid,
high-throughput characterization of the sequence specificities of DNA binding
proteins. Methods Mol Biol 338: 245–260.
24. Bulyk ML (2006) DNA microarray technologies for measuring protein-DNA
interactions. Curr Opin Biotechnol 17: 422–430.
25. Jolma A, Kivioja T, Toivonen J, Cheng L, Wei G, et al. Multiplexed massively
parallel SELEX for characterization of human transcription factor binding
specificities. Genome Res 20: 861–873.
26. Liu X, Clarke ND (2002) Rationalization of gene regulation by a eukaryotic
transcription factor: calculation of regulatory region occupancy from predicted
binding affinities. J Mol Biol 323: 1–8.
27. Hallikas O, Palin K, Sinjushina N, Rautiainen R, Partanen J, et al. (2006)
Genome-wide prediction of mammalian enhancers based on analysis of
transcription-factor binding affinity. Cell 124: 47–59.
28. Wang X, Gao H, Shen Y, Weinstock GM, Zhou J, et al. (2008) A high-
throughput percentage-of-binding strategy to measure binding energies in DNA-
protein interactions: application to genome-scale site discovery. Nucleic Acids
Res 36: 4863–4871.
29. Gustafsdottir SM, Schlingemann J, Rada-Iglesias A, Schallmeiner E, Kamali-
Moghaddam M, et al. (2007) In vitro analysis of DNA-protein interactions by
proximity ligation. Proc Natl Acad Sci U S A 104: 3067–3072.
30. Mukherjee S, Berger MF, Jona G, Wang XS, Muzzey D, et al. (2004) Rapid
analysis of the DNA-binding specificities of transcription factors with DNA
microarrays. Nat Genet 36: 1331–1339.
31. Badis G, Berger MF, Philippakis AA, Talukder S, Gehrke AR, et al. (2009)
Diversity and complexity in DNA recognition by transcription factors. Science
324: 1720–1723.
32. Zhu C, Byers KJ, McCord RP, Shi Z, Berger MF, et al. (2009) High-resolution
DNA-binding specificity analysis of yeast transcription factors. Genome Res 19:
556–566.
33. Warren CL, Kratochvil NC, Hauschild KE, Foister S, Brezinski ML, et al.
(2006) Defining the sequence-recognition profile of DNA-binding molecules.
Proc Natl Acad Sci U S A 103: 867–872.
34. Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, et al. (2004)
Transcriptional regulatory code of a eukaryotic genome. Nature 431: 99–104.
35. MacIsaac KD, Wang T, Gordon DB, Gifford DK, Stormo GD, et al. (2006) An
improved map of conserved regulatory sites for Saccharomyces cerevisiae. BMC
Bioinformatics 7: 113.
36. Borneman AR, Zhang ZD, Rozowsky J, Seringhaus MR, Gerstein M, et al.
(2007) Transcription factor binding site identification in yeast: a comparison of
high-density oligonucleotide and PCR-based microarray platforms. Funct Integr
Genomics 7: 335–345.
37. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, et al. (2006) A global map of p53
transcription-factor binding sites in the human genome. Cell 124: 207–219.
38. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, et al. (2007) Genome-
wide profiles of STAT1 DNA association using chromatin immunoprecipitation
and massively parallel sequencing. Nat Methods 4: 651–657.
39. Johnson DS, Mortazavi A, Myers RM, Wold B (2007) Genome-wide mapping of
in vivo protein-DNA interactions. Science 316: 1497–1502.
40. Stormo GD (2000) DNA binding sites: representation and discovery. Bioinfor-
matics 16: 16–23.
41. Berg OG, von Hippel PH (1987) Selection of DNA binding sites by regulatory
proteins. Statistical-mechanical theory and application to operators and
promoters. J Mol Biol 193: 723–750.
42. Granek JA, Clarke ND (2005) Explicit equilibrium modeling of transcription-
factor binding and gene regulation. Genome Biol 6: R87.
43. Manke T, Roider HG, Vingron M (2008) Statistical modeling of transcription
factor binding affinities predicts regulatory interactions. PLoS Comput Biol 4:
e1000039.
44. Roider HG, Kanhere A, Manke T, Vingron M (2007) Predicting transcription
factor affinities to DNA from a biophysical model. Bioinformatics 23: 134–141.
45. He X, Chen CC, Hong F, Fang F, Sinha S, et al. (2009) A biophysical model for
analysis of transcription factor interaction and binding site arrangement from
genome-wide binding data. PLoS One 4: e8155.
46. van Oeffelen L, Cornelis P, Van Delm W, De Ridder F, De Moor B, et al. (2008)
Detecting cis-regulatory binding sites for cooperatively binding proteins. Nucleic
Acids Res 36: e46.
47. Djordjevic M, Sengupta AM, Shraiman BI (2003) A biophysical approach to
transcription factor binding site discovery. Genome Res 13: 2381–2390.
48. Kinney JB, Tkacik G, Callan CG, Jr. (2007) Precise physical models of protein-
DNA interaction from high-throughput data. Proc Natl Acad Sci U S A 104:
501–506.
49. Wang J, Morigen (2009) BayesPI - a new model to study protein-DNA
interactions: a case study of condition-specific protein binding parameters for
Yeast transcription factors. BMC Bioinformatics 10: 345.
50. Foat BC, Morozov AV, Bussemaker HJ (2006) Statistical mechanical modeling
of genome-wide transcription factor occupancy data by MatrixREDUCE.
Bioinformatics 22: e141–149.
51. Gerland U, Moroz JD, Hwa T (2002) Physical constraints and functional
characteristics of transcription factor-DNA interaction. Proc Natl Acad Sci U S A
99: 12015–12020.
52. Stormo GD, Fields DS (1998) Specificity, free energy and information content in
protein-DNA interactions. Trends Biochem Sci 23: 109–113.
53. Hastings WK (1970) Monte Carlo sampling methods using Markov chains and
their applications. Biometrika 57: 97–109.
54. Gelman A (2004) Bayesian data analysis. Boca Raton, Fla.: Chapman & Hall/
CRC. xxv668 p.
55. Roberts GO, Gelman A, Gilks WR (1997) Weak Convergence and Optimal
Scaling of Random Walk Metropolis Algorithms. The Annals of Applied
Probability 7: 110–120.
56. Green PJ (1995) Reversible jump Markov chain Monte Carlo computation and
Bayesian model determination. Biometrika 82: 711–732.
57. Al-Awadhi F, Hurn M, Jennison C (2004) Improving the acceptance rate of
reversible jump MCMC proposals. Statistics & Probability Letters 69: 189–198.
58. Pollock DD, Chang BH (2007) Dealing with Uncertainty in Ancestral Sequence
Reconstruction: Sampling from the Posterior Distribution. In: Liberles DA, ed.
Ancestral Sequence Reconstruction. Oxford: Oxford University Press.
59. Haring M, Offermann S, Danker T, Horst I, Peterhansel C, et al. (2007)
Chromatin immunoprecipitation: optimization, quantitative analysis and data
normalization. Plant Methods 3: 11.
60. Friden P, Schimmel P (1988) LEU3 of Saccharomyces cerevisiae activates
multiple genes for branched-chain amino acid biosynthesis by binding to a
common decanucleotide core sequence. Mol Cell Biol 8: 2690–2697.
61. Foat BC, Morozov AV, Bussemaker HJ (2006) Statistical mechanical modeling
of genome-wide transcription factor occupancy data by MatrixREDUCE.
Bioinformatics 22: e141–149.
62. Gangelhoff TA, Mungalachetty PS, Nix JC, Churchill ME (2009) Structural
analysis and DNA binding of the HMG domains of the human mitochondrial
transcription factor A. Nucleic Acids Res 37: 3153–3164.
Bayesian Analysis of Protein-DNA Binding Affinity
PLoS ONE | www.plosone.org 15 November 2011 | Volume 6 | Issue 11 | e26105